Advances in early biomarkers of anthracyclines related to cardiotoxicity
10.11904/j.issn.1002-3070.2023.06.007
- VernacularTitle:蒽环类药物相关心脏毒性早期生物标志物研究进展
- Author:
Yajie LU
1
;
Lihong WANG
Author Information
1. 承德医学院附属医院血液内科(承德 067000)
- Keywords:
Anthracycline;
Cardiotoxicity;
Biomarker;
Research progress
- From:
Practical Oncology Journal
2023;37(6):496-501
- CountryChina
- Language:Chinese
-
Abstract:
Anthracyclines are one of the widely used anti-tumor drugs in clinical practice.Its dose-related cardiotoxicity can affect the quality of life and survival rate of cancer patients,so early identification of anthracycline related cardiotoxicity is particu-larly important.This article provides a review of the research progress on early biomarkers of anthracycline related cardiotoxicity.
